Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Made 8 minoxidil samples; 1 cocrystal, 7 salts formed.

Doctors need to be better prepared to assess and treat obesity in patients.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

SHBG may be a useful early indicator and treatment target for PCOS.

LCN may improve finasteride delivery for hair loss treatment.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Melatonin affects mouse skin and may regulate skin functions.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

K16 can partially replace K14 but causes hair loss and skin issues.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Improved hair loss treatment using special particles and surfactants.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Dendrobium officinale polysaccharides may help with hair growth, skin moisturization, and protection against oxidative damage.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

ECM molecules are crucial for hair growth and development.